



What is it famous for?  It’s not, really
— but one of the journals it publishes,
Development, is, if only for being one
of the few high-profile journals that
almost nobody complains about. 
How did it start?  It was founded in
1925 by George Bidder, a sponge
specialist who was also a shrewd
businessman with leanings towards
philanthropy. His wish to benefit
mankind took him into some unusual
enterprises, such as hotel management
and second-hand boat dealing. 
Why did it start?  The main purpose of
the Company was to rescue the ailing
British Journal of Experimental Biology,
then only two years old but already on
the brink of financial ruin. The
Company bought the journal for £200,
raising money by subscription among
Bidder’s biology-minded friends. The
journal continued to run at a loss for
two more years, finally turning around
in 1928 with a profit of £3 8s 5d, or
$5.00 at today’s exchange rate. 
What happened to the British Journal
of Experimental Biology?  It is still
published, as the Journal of
Experimental Biology, and now focuses
on comparative animal physiology.
Does the Company publish any other
journals?  The third research journal
in the stable, the Journal of Cell Science,
was founded as the Quarterly Journal of
Microscopical Science and given to the
Company by Bidder in 1946. Until
1987, Development was known as the
Journal of Embryology and Experimental
Morphology. The Company also
publishes a review journal, Bioessays. 
Why has Development become so
successful?  High standards for
production (made possible by the
Company’s enthusiastic acceptance of
desk-top publishing, and the fact that
it runs its own printing press) have
certainly helped, as did the name
change and modernization of format.
Still, J. Cell Sci. has essentially the
same advantages but remains
something of an also-ran. Much of the
credit for Development’s renaissance
goes to Chris Wylie, Editor-in-Chief,
for applying rigorous editorial
standards and recruiting a top-notch
team of associate editors. J. Cell Sci.
may have a harder row to hoe as it has
such effective, if little-loved,
competition from journals such as Cell
and the Journal of Cell Biology. Plans
are afoot for both Development and J.
Cell Sci. to be published twice each
month, starting next year.
Why does the organization have such
an odd name?  Although the
Company sounds like a cross between
a collection of Mafiosi and a mediaeval
guild, it must have seemed to Bidder
that the name explained his purpose
— a company ‘run by and for
biologists’ — very well. It is still run
by a board of professional biologists
who give their time free of charge to
this essentially charitable organization.
Where did the money for the printing
presses come from?  The journals, as
a group, have been only very modestly
profitable for the last 70 years. The
financial security of the Company
derives from the wizardry of its
treasurer, eminent insect physiologist
Simon Maddrell, who took the
Company’s funds (£16 000 in a savings
account) in hand in 1965 and made a
killing on the stock market.
What else does the Company do with
its money?  Much of its profits —
around $192 000 this year — are
ploughed back into science, as
meeting sponsorship, travel awards to
junior scientists and substantial
contributions to the coffers of the
three British Societies most closely
linked to the journals it publishes —
the Societies for Cell, Developmental,
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Albert Michelson, who as a young
experimentalist proved the jaw-
dropping proposition that the speed of
light is a constant regardless of the
movement of the light source,
declared in 1894, “It seems probable
that most of the grand underlying
principles have been firmly
established and that further advances
are to be sought chiefly in the rigorous
application of these principles to all
phenomena” [1]. It is disheartening,
but not surprising, that Lewis Wolpert,
one of the founders of modern
developmental biology, should make
an almost identical statement about
his own field a hundred years later [2].
Cell biology is now at a stage
analogous to physics at the end of the
last century. We can describe cellular
behavior reasonably well, and we have
the tools needed to “ . . . fill in the
details of how the thousands of genes
. . . work” [2]. But when we have done
that, it will mark the beginning of a
new phase, not the end of the field.
The next grand principles that will
revolutionize our thinking about cel-
lular and developmental biology will
not lie simply in the identification or
characterization of any particular gene
or gene product, any more than the
future of physics in Michelson’s day
lay in refinement of the measurement
of the speed of light. Paradigm shifts
come about when we think about
familiar data in unfamiliar ways. 
Although we cannot specifically
predict where the next major shifts in
our own field will arise, in biology we
are fortunate to have many areas where
observation has thus far outstripped
theory. By analogy with physics at the
turn of the century, we can expect that
some new insights into the nature of
life will evolve as we study phenom-
ena less and examine cause and effect
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